‘Positivity’ helped couple through fertility treatment

A patient of ours thanked RSCNJ for its attitude as well as its expertise:

“The staff is so friendly, responsible, and helpful. Their positivity is infectious and you just know that everything is going to work out. Thank you for staying with us and inspiring us through such an uneasy time for us.”

Let us help you through your fertility journey. Read more reviews like this one on our web site.

Posted in Uncategorized | Tagged | Leave a comment

Gestational carrier surrogacy services: Your 5-step plan

When a woman cannot carry a healthy pregnancy to term, or for same sex male couples who wish to build their family, they have the option of using a gestational carrier (surrogate). In this treatment, the eggs of either the intended parent or an egg donor are inseminated with sperm of the male partner or sperm donor, fertilized and grown to embryos. The embryo(s) will then be placed into the gestational carrier’s uterus during an embryo transfer.

It sounds complicated, but there is a simple, five-step plan to take you from screening to implantation. We have just added a handy infographic to our Gestational Carrier web page. Take a look, and if you have any questions, please contact us.

Posted in Uncategorized | Tagged , | Leave a comment

Mosaic embryos can succeed in IVF, study finds

New research confirms in a nonhuman primate model that mosaic embryos can adapt to their abnormalities and persist in development, resulting in positive IVF outcomes.

Mosaic embryos contain both normal and abnormal cells. The reason for this is because most embryos do not contain 46 perfect chromosomes. Some have more, others have fewer. The result is a common abnormality known as aneuploidy, which occurs in as many as 80 percent of human embryos. Because aneuploidy has been linked to a risk of in vitro fertilization failure, miscarriage and certain genetic orders or birth defects, mosaic embryos have not been considered ideal candidates for IVF transfer.

However, new research conducted by scientists at the Oregon National Primate Research Center at OHSU, in Portland, Oregon, gives new hope to those seeking infertility treatments. Their findings were published in the journal Genome Research.

According to Paula Amato, M.D., an associate professor of obstetrics and gynecology in the OHSU School of Medicine, this discovery could positively impact IVF processes for humans in the future. “While selecting embryos with a normal chromosome complement is preferred and carries a high chance of pregnancy success, it is not a guarantee. For patients with only mosaic embryos available for transfer, these findings suggest that in some cases, these embryos will result in apparently normal pregnancies.”

Posted in Uncategorized | Tagged , | Leave a comment

A ‘super thankful’ patient

A happy patient of ours celebrates her “little magical”:

“I want to thank the whole team at the Reproductive Science Center. What an amazing staff and loving doctors. You all helped create our little magical and for that we are super thankful.”

We are happy as well, for all the patients we help on their fertility journey. Read more reviews like these on our web site.

Posted in Uncategorized | Tagged | Leave a comment

Another study links BPA with fertility concerns

Previous studies have shown the adverse health effects of prenatal exposure to the industrial chemical bisphenol A (BPA), but there is little evidence surrounding effects specifically on ovarian function. A new study now finds there is sufficient data to raise concerns regarding exposure and ovarian performance.

Detectable in surface water and soil sediments, BPA is used in many industrial processes (epoxy resins, polycarbonate plastic production) and in the lining of food cans. While the greatest exposure is dietary from canned foods and plastic containers, skin exposure is a secondary route of smaller exposure.

According to the researchers, ovarian development and function represents a complex coordination of processes, starting early during prenatal development. Early aberrations have the potential to carry through the female reproductive lifespan.

To examine whether a prenatal environmental exposure can pose a real threat to human ovarian function, researchers from Boston University School of Medicine (BUSM) performed a literature search in PubMed (from 2000 to June 2018), to examine existing literature surrounding prenatal exposure to BPA.

“We found there is mounting evidence for the effects of these exposures in the prenatal period, a particularly vulnerable time of development,” said corresponding author Shruthi Mahalingaiah, MD, MS, assistant professor of obstetrics and gynecology at BUSM. “Whether there are causative associations with human ovulation disorders needs to be further studied.”

The researchers believe their findings are particularly relevant since there are implications for both fetal and women’s health. “Understanding the effect that BPA exposure has on ovarian outcomes may contribute to the treatment approach taken for diseases and disorders in which ovarian dysfunction is a manifestation such as infertility, polycystic ovary syndrome and premature ovarian failure,” added Mahalingaiah, an obstetrician/gynecologist at Boston Medical Center.

Posted in Uncategorized | Tagged , | Leave a comment

Two great experiences

Two patients of ours have “great” things to say about their care here.

“Our experience with Dr. Martinez and the entire staff was great.”

“Great experience!! Dr. Mensah is so professional and warming!!”

Thanks to them for the “great” reviews. Please read more like these at our web site.

Posted in Uncategorized | Tagged | Leave a comment

This March, take part in Endometriosis Awareness Month

Endometriosis affects an estimated 176 million women worldwide. Although this comes to about 1 in 10 women, the average diagnosis can take up to seven and a half years. That can have a devastating effect on the quality of life of those of this condition, because of the painful symptoms that the disease carries and because it is the one of the biggest causes of infertility in women.

Every March, Endometriosis Awareness Month takes place across the world. It hopes to increase awareness and highlight the symptoms of this debilitating condition. To learn more, go to the Speak Endo web page, and check out our endometriosis web page to learn about our treatment options.

Posted in Uncategorized | Tagged | Leave a comment

Help us raise awareness about endometriosis

Endometriosis is a progressive disease that affects over 176 million women worldwide. In women with this condition, the endometrial tissue lining the inside of the uterus grows outside the uterus and attaches to other abdominal cavity organs such as the fallopian tubes or ovaries. Symptoms often include abnormal and painful menstrual bleeding, pain during or after sexual intercourse and infertility.

An estimated 1 in 10 women are affected in their reproductive years. Yet diagnosis is often delayed due to general lack of awareness of the condition by women and healthcare providers. This is often because symptoms are considered “normal” after women first experience them.

That’s why we encourage you to recognize National Endometriosis Awareness Month in March. Although endometriosis is incurable and can reoccur after treatment, our doctors can offer care to minimize pain and to help achieve pregnancy.

You can learn more about endometriosis by endometriosis, contacting us onlinerequesting an appointment or calling any of our three locations.

We also encourage you to visit the web site SpeakEndo.com. This organization encourages women to speak up about their symptoms and experiences to increase awareness around this disease.

Posted in Uncategorized | Leave a comment

New robotic technology diagnoses reproductive health problems in real time

Researchers have developed new robotic sensor technology that has the capability to diagnose women’s reproductive health problems in real time. The technology, developed by researchers at Imperial College London and the University of Hong Kong, can be used to measure hormones that affect fertility, sexual development and menstruation more quickly and cheaply than current methods.

According to the research, published in Nature Communications, doctors usually diagnose infertility and early menopause by carrying out a blood test to measure the amount of luteinizing hormone (LH) in the sample. Current blood tests cannot easily measure the rise and fall of LH levels, which is vital for normal fertility.

The researchers used a novel biosensor linked to a robotic system, which they call Robotic APTamer-enabled Electrochemical Reader (RAPTER). It monitors the hormone patterns of patients in real time. In the study, the prototype RAPTER device was used to measure LH in the blood of patients taken every 10 minutes to yield an immediate result. The researchers believe that it could pave the way for more personalized medicine by giving clinicians a clearer picture of LH levels and suggesting more effective treatments based on an individual’s needs.

Posted in Uncategorized | Tagged | Leave a comment

Praise for our doctors and staff

Two patients of RSCNJ had nice things to say about their care here.

“Because of extra testing the doctor recommended, I found out I needed to be on progesterone for longer. After adjusting my protocol, we had a successful transfer and I’m currently 8 weeks pregnant!”

“Dr. Mensah was wonderful and patient through all of my questions. She was supportive and clear as to what to expect. The staff was always kind and helpful.”

We thank them for taking the time to post these kind words. You can read more reviews like these on our web site.

Posted in Uncategorized | Tagged | Leave a comment